This retrospective observational study used the Victorian Admitted Episodes Dataset (VAED), which captures all hospital admissions in the state of Victoria and is provided by the Victorian Department of Health. Records from July 2013 to June 2023 were screened for admissions coded for cannabis-related poisoning and mental and behavioural disorders using ICD codes T40.7 (poisoning by cannabis) and F12.0–F12.9 (mental and behavioural disorders due to cannabinoids).
The authors report crude and age-standardised rates of admissions per 100,000 population. Net percentage change across the ten-year window was estimated using generalised linear models with a log-population offset, contrasting the final study year (2022/23) against the baseline year (2013/14). All data produced are reported in the manuscript; data provenance and ethical approvals are stated.
Across the ten-year period there were 39,565 cannabis-related hospital admissions. Of these, 7,263 admissions listed a cannabis-related condition as the principal diagnosis. Age-standardised rates were 63.6 per 100,000 population for all cannabis-related harm admissions and 11.7 per 100,000 when restricted to principal-diagnosis cases.
Annual rates were non-linear over the study window. The highest annual rate for all cannabis-related harm admissions occurred in 2020/2021 at 77.3 admissions per 100,000. Comparing 2022/23 with the baseline year 2013/14, the rate of hospital admissions with a cannabis-related principal diagnosis increased by 49.0% (p < 0.0001) according to model estimates. The authors note that rates in the final two years were lower than the 2020/2021 peak, indicating that the increase was not strictly monotonic over time.
Within the F12 mental and behavioural disorder codes, harmful use (F12.1) was the most frequently recorded category. Psychotic disorder due to cannabinoids (F12.5) was the most common single diagnosis reported in a presented subgroup, comprising 45.3% of that group (n = 2,909 of 6,421 cases where this breakdown was provided).
When analyses were restricted to principal diagnoses, the highest admission rates were observed in younger people. Males aged 15–24 years had the highest principal-diagnosis rate at 36.9 per 100,000, followed by females aged 15–24 years at 20.5 per 100,000. Overall, the majority of principal-diagnosis cases involved males.
Despite a male predominance in absolute counts, the relative increase across the decade was greater for females. The rate for females rose by 75.1% between 2013/14 and 2022/23 (p < 0.0001), while the increase for males was 34.6% (p = 0.003). These sex-specific percentage changes were estimated using the study's modelling approach.
This analysis is based on administrative hospital coding and is subject to limitations inherent to routinely collected data (for example, coding practices and diagnostic specificity). The manuscript is a preprint and has not been peer reviewed; the authors explicitly state it should not be used to guide clinical practice. Ethical approval for custody and use of the hospital and emergency department data is reported from Monash University Human Research Ethics Committee (project ID 44606). Funding sources declared include NHMRC grants and an Australian Research Council Future Fellowship.
Over the decade from 2013/14 to 2022/23 there were 39,565 cannabis-related hospital admissions in Victoria, with 7,263 cases where cannabis-related harm was the principal diagnosis. The study documents a 49% increase in the rate of admissions with a cannabis-related principal diagnosis comparing 2022/23 to 2013/14, with notable contributions from mental and behavioural disorders due to cannabinoids and a high proportion of psychotic disorder diagnoses among affected cases. Trends were non-linear, with a peak in 2020/2021 and somewhat lower rates in the final two study years. The authors report demographic concentration in young people and a larger relative rise among females, and they emphasize that findings are derived from administrative data and reported in a preprint that has not undergone peer review.